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Background: Concurrent diseases, multiple pathologies and multimorbidity patterns are topics of increased interest
as the world’s population ages. To explore the impact of multimorbidity on affected patients and the consequences
for health services, we designed a study to describe multimorbidity by sex and life-stage in a large population
sample and to assess the association with acute morbidity, area of residency and use of health services.
Methods: A cross-sectional study was conducted in Catalonia (Spain). Participants were 1,749,710 patients aged
19+ years (251 primary care teams). Primary outcome: Multimorbidity (≥2 chronic diseases). Secondary outcome:
Number of new events of each acute disease. Other variables: number of acute diseases per patient, sex, age group
(19–24, 25–44, 45–64, 65–79, and 80+ years), urban/rural residence, and number of visits during 2010.
Results: Multimorbidity was present in 46.8% (95% CI, 46.7%-46.8%) of the sample, and increased as age increased,
being higher in women and in rural areas. The most prevalent pair of chronic diseases was hypertension and lipid
disorders in patients older than 45 years. Infections (mainly upper respiratory infection) were the most common
acute diagnoses. In women, the highest significant RR of multimorbidity vs. non-multimorbidity was found for
teeth/gum disease (aged 19–24) and acute upper respiratory infection. In men, this RR was only positive and significant
for teeth/gum disease (aged 65–79). The adjusted analysis showed a strongly positive association with multimorbidity
for the oldest women (80+ years) with acute diseases and women aged 65–79 with 3 or more acute diseases,
compared to patients with no acute diseases (OR ranged from 1.16 to 1.99, p < 0.001). Living in a rural area was
significantly associated with lower probability of having multimorbidity. The odds of multimorbidity increased
sharply as the number of visits increased, reaching the highest probability in those aged 65–79 years.
Conclusions: Multimorbidity is related to greater use of health care services and higher incidence of acute
diseases, increasing the burden on primary care services. The differences related to sex and life-stage observed for
multimorbidity and acute diseases suggest that further research on multimorbidity should be stratified according
to these factors.
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Concurrent diseases, multiple pathologies and multimor-
bidity patterns are topics of increased interest as the
world’s population ages [1]. Multimorbidity is the coex-
istence of two or more chronic health problems in the
same person at one point in time [2], and multimorbidity
patterns are any combination of chronic diseases [3]. Both
considerations have important consequences for the indi-
vidual and for health services [4]. Multimorbidity is a chal-
lenge for industrialized countries and can jeopardize the
viability of national health systems.
Traditionally, the construct of multimorbidity has been
inherently associated with persistent or chronic disease.
Methods to measure multimorbidity include disease
scores, case-mix systems, indexes and disease counts,
the latter being the common method [5]. Far too little
attention has been paid to the use of health services and
the role of urban or rural residency in patients with
multimorbidity [6,7]. Furthermore, the literature lacks
comparisons by sex of acute morbidity in patients with
multimorbidity in a large population sample [8,9].
The classification of acute and chronic disease remains
controversial. Acute disease is characterized by a single or
repeated episode of relatively rapid onset and short dur-
ation with a recovery to previous stage of activity [10].
Nevertheless, some diseases fall into a grey area. Know-
ledge of specific acute diseases that may occur more fre-
quently than expected and of the underlying vulnerabilities
[11] could help to focus attention on the patients with
multimorbidity rather than emphasizing the diseases.
To explore the impact of multimorbidity on affected
patients and the consequences for health services, we
designed a study to describe multimorbidity by sex and
life-stage in a large population sample and to assess the
association with acute morbidity, area of residency and
use of health services.
Methods
Data source and study population
Cross-sectional study of adults resident in Catalonia, a
Mediterranean region of southern European with 7,434,632
inhabitants (2010 census), 16% of the population of
Spain. In Catalonia, 358 primary health care teams
(PHCT) comprised of doctors, nurses, social workers
and support staff are assigned by geographical area and
responsible for the health care of the population in their
areas. The Catalan Health Institute (CHI) manages 274
PHCT (76.5%), serving a population of 4,859,725 adults;
the remaining PHCT are managed by other providers.
Doctors and nurses systematically use electronic health
records (EHR) to record diagnoses, prescriptions and
other clinical, patient management and administrative ac-
tivities. The CHI Information System for the Development
of Research in Primary Care (SIDIAP) [12] compiles codedclinical information from the EHR system. A subset of
SIDIAP records meeting the highest quality criteria for
clinical data (SIDIAP-Q) includes 40% of the SIDIAP
population (1,936,443 patients), attended by the 1,319
general practitioners (GP) whose data recording scored
highest in a validated comparison process. The sample
is representative of the general Catalan population in
terms of geography, age and sex distributions, according
to the official 2010 census [13].
A sample of 1,749,710 patients aged 19 years or older,
assigned to 251 PHCT during the period of study (1
January- 31 December 2010), was selected from the
SIDIAP-Q database.
Coding of diseases
International Classification of Diseases (ICD-10) codes were
mapped to the International Classification of Primary Care
(ICPC-2e-v.4.2, available at: http://www.kith.no/templates/
kith_WebPage____1111.aspx). R codes (symptoms, signs
and abnormal clinical and laboratory findings, not else-
where classified) and Z codes (factors influencing health
status and contact with health services) were excluded,
resulting in 686 included codes. Each diagnosis was then
classified using O’Halloran criteria for chronic disease [14].
We included all 146 diagnoses considered as chronic
diseases by O’Halloran criteria: (i) have a duration that
has lasted, or is expected to last, at least 6 months; (ii)
have a pattern of recurrence or deterioration; (iii) have a
poor prognosis and (iv) produce consequences, or se-
quelae, that have an impact on the individual’s quality of
life [14,15]. Any disease not meeting the O’Halloran cri-
teria was considered an acute disease.
All results were described with ICPC-2 codes. Diseases
were classified as acute if diagnosed during the study
period and chronic if recorded as such in EHR as of 31
December 2010.
Outcomes and variables
The main outcome was multimorbidity, defined as the
coexistence of 2 or more chronic diseases. Secondary
outcome was the number of new events of each acute
disease. Other variables recorded for each patient were
the following: number of all acute diseases (0, 1, 2, > = 3),
sex (male, female), age (young adult, 19 to 24; adult, 25–
44; older adult, 45–64; elderly, 65–79; and oldest adult,
80+), number of visits during the study period (0, 1–2,
3–5, 6–10, ≥11), and area of residence (rural if <10,000
inhabitants and/or population density <150 people/km2,
otherwise urban) [14]. Number of all acute diseases (or
0 diseases) and visits (or 0 visits) were categorized as
quartiles of the study population. Number of visits was
used as a proxy of use of health services and included
visits recorded in EHR by GP, nurses or social workers,
either at the primary care centre or as home health care.
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Analysis was stratified by sex and age group. Descriptive
statistics were used to summarize overall information.
Categorical variables were expressed as frequencies (per-
centage) and continuous as mean (Standard deviation, SD)
or median (interquartile range, IQR).
Cumulative incidence of acute morbidity events was
calculated as the number of new acute events during the
study period divided by the at-risk population in the
sample (e.g., if a patient had bronchitis twice in the one-
year study period, the total number of events accounted
for was 2). We took into account the five acute diseases
with the highest cumulative incidence within each stratum.
Risk ratios (RR) of multimorbidity vs. non-multimorbidity
were calculated for the number of events for each acute
disease, using Poisson, negative binomial (if overdispersion
was present) or zero inflated (when data had an excess of
zero counts) equations, as appropriate. All models were
adjusted for number of visits and area of residency.
To determine the most prevalent multimorbidity pat-
terns, all possible combinations of any two chronic dis-
eases and their frequencies were calculated. Observed (O)
and expected (E) prevalence of those two chronic diseases
with each acute disease was then computed. Expected co-
occurrence of diseases was obtained as the product of
these prevalences, assuming statistical independence of
the diseases concerned. The overlapping of those combi-
nations that presented the highest O/E ratio was reported.
Logistic regression was used to assess the association
between multimorbidity and the variables listed above.
All statistical tests were two-sided at the 5% signifi-
cance level. The analyses were performed using SPSS for
Windows, version 18 (SPSS Inc., Chicago, IL, USA), Stata/
SE version 11 for Windows (Stata Corp. LP, College
Station, TX, USA) and R version 2.15.2 (R Foundation
for Statistical Computing, Vienna, Austria).
Ethical considerations
The study protocol was approved by the Committee on
the Ethics of Clinical Research, Institut Universitari
d’Investigació en Atenció Primària (IDIAP) Jordi Gol
(Protocol No: P12/28). All data were anonymized and
the confidentiality of EHR was respected at all times in
accordance with international law.
Results
We included 1,749,710 patients; mean age was 47.4 years
(SD: 17.8), 50.7% were female and 16% lived in rural areas.
Multimorbidity (≥ 2 diseases) was present in 46.8% (95%
CI, 46.7%-46.8%) of the sample, being higher in female
(52.3%) than in male (41.1%) and in rural areas (47.6%)
than in urban areas (46.6%).
The prevalence of the most common chronic diseases
differed by sex below 45: anxiety disorder/anxiety (womenaged 19–44); acne (men aged 19–24) and lipid disorder
(men aged 25–44). After 45 both sex groups first chronic
disease was lipid disorder in 45–64 and uncomplicated
hypertension in 65-80+ (Table 1). Upper respiratory infec-
tion acute is the most incident acute disease in all age
groups (except in 80+).
Multimorbidity prevalence increased as age increased,
being higher in female (ranged from 19.0% to 92.1%) than
male (ranged from 12.9% to 92.0%). In patients with multi-
morbidity, the number of acute diseases was higher in
female than male and decreased as age increased, except
in male older than 65. In addition, the number of visits
increased as age increased, and was higher for female
than male in all age groups except 80+ (Table 2).
Patients with multimorbidity had a higher incidence of
acute diseases and number of visits in all age strata than
non-multimorbidity patients; in both cases, the incidence
was higher for female than male (Table 2). Overall, the
median (IQR) of number of visits was 8(4–14) in patients
with multimorbidity vs. 1(0–4) in the non-multimorbidity
group.
The two most prevalent combinations of two chronic
diseases were hypertension and lipid disorders in patients
older than 45 years. The only acute disease that appeared
in both sexes was “bursitis/tendinitis/synovitis NOS” in
the oldest age group (80+). In the other age groups, the
acute health disease varied by sex (Figure 1).
The five acute diseases with the highest cumulative in-
cidence were similar by sex in any age group. Infections
were the most common diagnosis. Cystitis/urinary infec-
tion was present among the five most prevalent acute
conditions only in women and in the oldest men. In
women, the highest significant RR of multimorbidity vs.
non-multimorbidity was found for teeth/gum disease
(aged 19–24) and upper respiratory infection, acute (80+).
In men, this RR was only positive and significant for teeth/
gum disease (aged 65–79) (Table 3).
The adjusted analysis of factors associated with multi-
morbidity showed that the oldest patients (80+ years)
with acute diseases and women aged 65–79 with 3 or
more acute diseases were more likely to have multimor-
bidity than patients with no acute diseases. This positive
association was only significant in women. Living in a
rural area was significantly associated with lower prob-
ability of having multimorbidity. Patients who visited a
GP more often were more likely than those without
visits to have multimorbidity, reaching the highest prob-
ability in those aged 65–79 years (Table 4).
Discussion
Statement of principal findings
Almost half of the study population had multimorbidity,
with infections (mainly acute upper respiratory infection)
the most common acute disease in both sexes and all age
Table 1 Five highest cumulative incidence of acute and prevalence of chronic diseases by sex and age groups
Female Male
Age
groups
ICPC Chronic diseases Prevalence
(%, CI)
ICPC Acute diseases Cumulative
incidence (%, CI)
ICPC Chronic diseases Prevalence
(%, CI)
ICPC Acute diseases Cumulative
incidence (%, CI)
19-24 P74 Anxiety disorder/
anxiety state
8.4 (8.2-8.7) R74 Upper respiratory
infection acute
9.1 (8.9-9.3) S96 Acne 7.7 (7.5-7.9) R74 Upper respiratory
infection acute
6.9 (6.7-7.1)
S96 Acne 7.8 (7.6-8.0) R76 Tonsillitis acute 4.4 (4.3-4.6) R96 Asthma 6.0 (5.8-6.2) R76 Tonsillitis acute 3.4 (3.3-3.6)
R96 Asthma 5.4 (5.2-5.6) U71 Cystitis/urinary
infection other
4.1 (4.0-4.3) P74 Anxiety disorder/
anxiety state
3.9 (3.7-4.0) D73 Gastroenteritis
presumed infection
2.9 (2.8-3.0)
T82 Obesity 5.0 (4.8-5.1) D82 Teeth/gum disease 3.7 (3.5-3.8) T82 Obesity 3.4 (3.3-3.6) D82 Teeth/gum disease 2.5 (2.4-2.7)
L85 Acquired deformity
of spine
4.6 (4.4-4.8) D73 Gastroenteritis
presumed infection
3.6 (3.5-3.8) L85 Acquired deformity
of spine
3.1 (3.0-3.2) S16 Bruise/contusion 2.3 (2.2-2.4)
25-44 P74 Anxiety disorder/
anxiety state
12.2 (12.1-12.3) R74 Upper respiratory
infection acute
7.8 (7.7-7.9) T93 Lipid disorder 7.3 (7.2-7.4) R74 Upper respiratory
infection acute
5.9 (5.8-5.9)
P76 Depressive disorder 8.8 (8.7-8.9) L03 Low back symptom/
complaint
3.4 (3.3-3.5) P74 Anxiety disorder/
anxiety state
6.5 (6.4-6.6) D73 Gastroenteritis
presumed infection
2.4 (2.4-2.5)
T82 Obesity 6.8 (6.7-6.9) U71 Cystitis/urinary
infection other
2.9 (2.8-2.9) T82 Obesity 4.4 (4.4-4.5) L03 Low back symptom/
complaint
2.4 (2.3-2.4)
T93 Lipid disorder 5.0 (4.9-5.0) D73 Gastroenteritis
presumed infection
2.8 (2.8-2.9) P76 Depressive disorder 3.7 (3.7-3.8) D82 Teeth/gum disease 2.1 (2.1-2.2)
N89 Migraine 4.9 (4.8-4.9) R76 Tonsillitis acute 2.6 (2.6-2.7) L86 Back syndrome with
radiating pain
3.5 (3.4-3.5) R76 Tonsillitis acute 1.8 (1.8-1.9)
45-64 T93 Lipid disorder 28.4 (28.2-28.5) R74 Upper respiratory
infection acute
7.0 (6.9-7.1) T93 Lipid disorder 29.9 (29.7-30.1) R74 Upper respiratory
infection acute
4.8 (4.7-4.9)
K86 Hypertension
uncomplicated
21.2 (21.1-21.4) L03 Low back symptom/
complaint
3.2 (3.1-3.3) K86 Hypertension
uncomplicated
24.6 (24.4-24.7) L03 Low back symptom/
complaint
2.6 (2.5-2.7)
P76 Depressive disorder 18.9 (18.8-19.1) U71 Cystitis/urinary
infection other
2.9 (2.8-3.0) T82 Obesity 10.9 (10.8-11.0) R78 Acute bronchitis/
bronchiolitis
2.0 (2.0-2.1)
T82 Obesity 15.7 (15.6-15.9) R78 Acute bronchitis/
bronchiolitis
2.8 (2.7-2.9) T90 Diabetes non-insulin
dependent
10.3 (10.2-10.5) D82 Teeth/gum disease 2.0 (2.0-2.1)
P74 Anxiety disorder/
anxiety state
13.5 (13.4-13.6) L20 Joint symptom/
complaint NOS
2.6 (2.6-2.7) L86 Back syndrome with
radiating pain
7.6 (7.5-7.7) H81 Excessive ear wax 1.9 (1.9-2.0)
65-79 K86 Hypertension
uncomplicated
60.3 (60.0-60.6) R74 Upper respiratory
infection acute
7.2 (7.1-7.3) K86 Hypertension
uncomplicated
56.2 (55.9-56.5) R74 Upper respiratory
infection acute
6.4 (6.2-6.5)
T93 Lipid disorder 52.4 (52.1-52.7) U71 Cystitis/urinary
infection other
4.3 (4.2-4.4) T93 Lipid disorder 44.6 (44.3-44.9) H81 Excessive ear wax 3.9 (3.8-4.0)
T82 Obesity 24.9 (24.7-25.1) R78 Acute bronchitis/
bronchiolitis
3.8 (3.7-3.9) Y85 Benign prostatic
hypertrophy
28.4 (28.1-28.7) R78 Acute bronchitis/
bronchiolitis
3.5 (3.4-3.6)
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Table 1 Five highest cumulative incidence of acute and prevalence of chronic diseases by sex and age groups (Continued)
L95 Osteoporosis 22.8 (22.5-23.0) H81 Excessive ear wax 3.0 (2.9-3.1) T90 Diabetes non-insulin
dependent
25.6 (25.4-25.9) D82 Teeth/gum disease 2.4 (2.3-2.5)
P76 Depressive disorder 22.3 (22.1-22.5) L03 Low back symptom/
complaint
2.8 (2.7-2.9) T82 Obesity 15.4 (15.2-15.6) L03 Low back symptom/
complaint
2.3 (2.2-2.4)
80+ K86 Hypertension
uncomplicated
73.1 (72.7-73.4) R74 Upper respiratory
infection acute
5.1 (4.9-5.2) K86 Hypertension
uncomplicated
63.4 (62.9-63.9) H81 Excessive ear wax 5.8 (5.6-6.1)
T93 Lipid disorder 44.5 (44.1-44.9) U71 Cystitis/urinary
infection other
5.0 (4.9-5.2) Y85 Benign prostatic
hypertrophy
37.3 (36.8-37.8) R74 Upper respiratory
infection acute
5.4 (5.1-5.6)
L91 Osteoarthrosis other 25.7 (25.4-26.1) R78 Acute bronchitis/
bronchiolitis
4.5 (4.4-4.7) T93 Lipid disorder 35.0 (34.5-35.5) R78 Acute bronchitis/
bronchiolitis
4.9 (4.7-5.2)
F92 Cataract 23.5 (23.2-23.8) H81 Excessive ear wax 4.2 (4.0-4.4) T90 Diabetes non-insulin
dependent
25.4 (24.9-25.9) S18 Laceration/cut 3.8 (3.6-4.0)
T90 Diabetes non-
insulin dependent
22.8 (22.5-23.1) S18 Laceration/cut 3.4 (3.3-3.6) F92 Cataract 21.9 (21.4-22.3) U71 Cystitis/urinary
infection other
2.7 (2.6-2.9)
Abbreviations: ICPC 2 International Classification of Primary Care, CI Confidence interval.
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Table 2 Multimorbidity prevalence and acute diseases, area of residency and visits according to multimorbidity status
stratified by sex and age groups
Female
19-24 25-44 45-64 65-79 ≥80
MM Non-MM MM Non-MM MM Non-MM MM Non-MM MM Non-MM
n = 12,804
(19.0%)
n = 54,700
(81.0%)
n = 105,463
(29.4%)
n = 253,771
(70.6%)
n = 167,778
(63.3%)
n = 97,089
(36.7%)
n = 119,528
(90.2%)
n = 13,021
(9.8%)
n = 58,533
(92.1%)
n = 5,021
(7.9%)
Number of
acute diseases
Median (IQR) 1 (0–2) 0 (0–1) 1 (0–2) 0 (0–1) 1 (0-2) 0 (0–1) 1 (0–1) 0 (0–0) 0 (0–1) 0 (0–0)
0 36.4 55.3 40.2 60.3 44.8 68.2 47.7 78.0 51.5 82.3
1 26.8 23.7 27.1 22.3 27.6 19.4 27.4 14.9 26.2 12.3
2 16.9 11.6 16.1 10.2 14.7 7.8 13.7 4.9 12.7 3.7
≥3 19.9 9.4 16.6 7.2 12.9 4.6 11.2 2.3 9.7 1.8
Living in a rural
area
14.4 14.9 15.3 15.1 15.4 16.7 15.4 17.6 18.4 18.7
Number of
visits
Median (IQR) 6 (3–10) 2 (0–5) 6 (3–11) 2 (0–5) 8 (4–13) 2 (0–5) 11 (7–18) 2 (0–5) 14 (8–24) 1 (0–7)
0 8.8 28.4 9.8 34.2 5.8 38.3 2.6 38.9 3.0 40.4
1-2 15.4 24.4 14.7 22.9 10.4 21.6 4.4 18.6 4.2 16.2
3-5 25.0 23.6 23.1 21.5 20.5 20.1 11.9 18.0 9.1 14.0
6-10 27.1 15.8 26.7 14.5 28.7 13.5 26.5 15.5 20.4 13.4
≥11 23.6 7.8 25.7 6.9 34.6 6.4 54.7 9.0 63.4 16.0
Male
19-24 25-44 45-64 65-79 ≥80
MM Non-MM MM Non-MM MM Non-MM MM Non-MM MM Non-MM
n = 8,916
(12.9%)
n = 60,373
(87.1%)
n = 75,556
(19.5%)
n = 311,124
(80.5%)
n = 139,776
(54.0%)
n = 119,008
(46.0%)
n = 97,044
(86.9%)
n = 14,584
(13.1%)
n = 32,773
(92.0%)
n = 2,948
(8.0%)
Number of
acute diseases
Median (IQR) 1 (0–1) 0 (0–1) 0 (0–1) 0 (0–1) 0 (0–1) 0 (0–1) 0 (0–1) 0 (0–0) 0 (0–1) 0 (0–0)
0 49.0 64.6 50.8 68.1 55.3 74.0 53.2 76.4 52.0 78.9
1 26.1 21.7 26.4 20.0 26.0 17.3 26.9 16.0 27.1 13.7
2 13.7 8.4 12.8 7.6 11.3 5.9 12.0 5.3 11.9 4.6
≥3 11.1 5.2 10.0 4.4 7.4 2.8 8.0 2.3 8.9 2.8
Living in a rural
area
15.0 15.1 15.6 15.3 17.3 17.5 16.7 18.8 21.3 21.5
Number of
visits
Median (IQR) 4 (1–8) 1 (0–4) 5 (2–9) 1 (0–3) 6 (3–12) 1 (0–3) 11 (6–17) 2 (0–6) 14 (8–24) 2 (0–8)
0 15.0 38.7 14.2 43.8 8.9 46.1 2.8 36.0 2.3 35.2
1-2 21.6 26.3 18.4 24.0 13.4 21.7 5.3 19.4 3.5 16.3
3-5 26.1 19.8 24.4 18.0 22.1 17.1 13.4 18.8 8.8 15.5
6-10 22.5 10.8 23.2 10.0 26.9 10.3 28.1 16.1 20.8 14.2
≥11 14.8 4.4 19.8 4.2 28.7 4.7 50.4 9.7 64.5 18.8
Abbreviations: MM multimorbidity, IQR interquartile range. Data are expressed as percentage, unless otherwise stated.
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19-24 25-44 45-64 65-79 80+
Female
Male
Chronic diseases: green and red lettering. Acute disease: blue lettering. Value of observed prevalence expressed as percentage.  
* Expected co-occurrence of diseases was obtained as the product of the separate prevalences, assuming statistical independence of the diseases concerned. 
Figure 1 Most prevalent multimorbidity patterns of two chronic diseases and the corresponding acute disease with the highest
observed/expected ratio*, by sex and age groups.
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chronic diseases was the combination of hypertension
and dyslipidemia in adults over 45 years of age.
We observed a decrease in the number of acute dis-
eases recorded as age increased. Nonetheless, in adjusted
models female older than 65 who had acute diseases
were more likely to have multimorbidity.
Finally, the use of health services was positively associ-
ated with a diagnosis of multimorbidity. Living in a rural
area decreased the probability of multimorbidity.Strengths and weaknesses of the study
A major strength of this study is the analysis of a large,
high-quality database of primary-care records, represen-
tative of a large population. In the context of a national
health system with universal coverage, EHR data have
been shown to yield more reliable and representative
conclusions than those derived from survey-based studies
[16]. Another important strength was the inclusion of all
chronic and acute diagnoses registered in EHR, which
contributed to a more accurate analysis of the association
between acute and chronic diseases and of the disease
combinations present in multimorbidity in this popula-
tion. To synthesize the results, we present here only the
most frequent combinations. Finally, few studies have in-
corporated acute diseases in the study of multimorbidity
patterns [8] and none analyzed the relationship between
multimorbidity and acute morbidity.Some possible biases could have influenced our results.
First, diseases could be underreported, especially for male
of normal workforce age who tend to see their doctors less
often than other strata of patients. This effect would dimin-
ish in the two oldest age groups because of the retirement
age (65 years) in Spain. In patients with multimorbidity, the
true incidence of acute disease could be underreported be-
cause the GP would place higher priority on the chronic
problems in these patients. On the other hand, there could
be an over-representation of chronic diagnoses (e.g., hyper-
tension, diabetes, hyperlipidemia, etc.) that are included in
the goals/incentives contracts of Catalan PHCT.
The diseases that form part of the CatSalut treatment
objectives may be more carefully recorded than other con-
ditions. However, these same diseases are the most preva-
lent (high blood pressure, diabetes, hypercholesterolemia,
smoking, dyslipidemia, ischemic heart disease, atrial fibril-
lation) and therefore have the greatest impact on popula-
tion health. The quality-recorders database (SIDIAP-Q)
used in this study minimizes the under-reporting of dis-
eases not included in the CatSalut objectives.
Furthermore, the stratified analysis allows more accurate
estimation within each age-sex strata and universal access
to free health care and medications makes it more likely
that patients seeking care will acquire a diagnosis, either
acute or chronic [17,18]. Second, there is no universally
accepted criterion for consensus classification of acute and
chronic disease. This lack of accurate case definitions im-
pedes the establishment of the true incidence/prevalence
Table 3 Cumulative incidence and risk ratio (RR) of multimorbidity for the five acute diseases with the highest cumulative incidence by sex and age groups*#
Female Male
Age
groups
ICPC 2
code
Acute diseases MM
CI
Non-MM
CI
Risk ratio 95% confidence
interval
ICPC 2
code
Acute diseases MM
CI*
Non-MM
CI
Risk ratio 95% confidence
interval
(%) (%) (%) (%)
19-24 R74 Upper respiratory infection, acute 16.2 8.8 1.10 (1.04-1.16) R74 Upper respiratory infection, acute 11.9 7.0 0.96 (0.89-1.03)
R76 Tonsillitis, acute 6.7 4.3 0.94 (0.86-1.02) R76 Tonsillitis, acute 5.5 3.4 0.92 (0.83-1.02)
U71 Cystitis/urinary infection, other 6.3 4.1 0.85 (0.78-0.93) D73 Gastroenteritis, presumed infection 4.8 2.8 0.93 (0.83-1.04)
D82 Teeth/gum disease 6.2 3.6 1.14 (1.04-1.25) D82 Teeth/gum disease 4.3 2.7 0.63 (0.44-0.89)
D73 Gastroenteritis, presumed infection 6.3 3.4 1.06 (0.97-1.16) S16 Bruise/contusion 3.2 2.4 0.75 (0.66-0.86)
25-44 R74 Upper respiratory infection, acute 12.8 6.9 1.01 (0.98-1.03) R74 Upper respiratory infection, acute 9.9 5.7 0.85 (0.82-0.87)
L03 Low back symptom/complaint 4.4 3.1 0.73 (0.71-0.76) D73 Gastroenteritis, presumed infection 3.8 2.3 0.79 (0.76-0.83)
U71 Cystitis/urinary infection other 4.4 2.6 0.86 (0.83-0.90) L03 Low back symptom/complaint 3.5 2.2 0.75 (0.71-0.78)
D73 Gastroenteritis presumed infection 4.3 2.5 0.90 (0.87-0.94) D82 Teeth/gum disease 3.5 2.2 0.82 (0.72-0.93)
R76 Tonsillitis, acute 3.6 2.5 1.08 (0.91-1.29) R76 Tonsillitis, acute 2.4 1.8 0.69 (0.65-0.73)
45-64 R74 Upper respiratory infection, acute 9.7 4.5 0.92 (0.88-0.95) R74 Upper respiratory infection, acute 6.7 3.4 0.79 (0.76-0.82)
L03 Low back symptom/complaint 3.9 2.1 0.78 (0.74-0.82) L03 Low back symptom/complaint 3.2 2.1 0.58 (0.55-0.62)
U71 Cystitis/urinary infection, other 4.0 1.7 0.86 (0.81-0.92) R78 Acute bronchitis/bronchiolitis 3.0 1.3 0.86 (0.80-0.92)
R78 Acute bronchitis/bronchiolitis 3.9 1.6 0.95 (0.89-1.01) D82 Teeth/gum disease 2.9 1.6 0.83 (0.70-0.98)
L20 Joint symptom/complaint NOS 3.3 1.5 0.97 (0.82-1.15) H81 Excessive ear wax 2.5 1.4 0.74 (0.69-0.78)
65-79 R74 Upper respiratory infection, acute 8.4 3.2 0.92 (0.70-1.20) R74 Upper respiratory infection, acute 7.6 3.3 0.93 (0.84-1.03)
U71 Cystitis/urinary infection other 5.1 1.4 1.09 (0.91-1.30) H81 Excessive ear wax 4.4 2.3 0.74 (0.65-0.83)
R78 Acute bronchitis/bronchiolitis 4.5 1.3 0.71 (0.36-1.39) R78 Acute bronchitis/bronchiolitis 4.2 1.5 0.99 (0.85-1.14)
H81 Excessive ear wax 3.3 1.2 0.88 (0.74-1.04) D82 Teeth/gum disease 2.9 1.2 1.31 (1.10-1.57)
L03 Low back symptom/complaint 3.0 1.1 0.76 (0.54-1.07) L03 Low back symptom/complaint 2.5 1.1 0.87 (0.73-1.03)
80+ R74 Upper respiratory infection, acute 5.8 1.5 1.47 (1.16-1.86) H81 Excessive ear wax 6.5 2.7 0.98 (0.77-1.24)
U71 Cystitis/urinary infection, other 5.9 1.5 1.40 (1.10-1.78) R74 Upper respiratory infection, acute 6.2 2.0 1.29 (0.98-1.70)
R78 Acute bronchitis/bronchiolitis 5.3 2.0 0.99 (0.80-1.23) R78 Acute bronchitis/bronchiolitis 5.7 2.0 1.06 (0.80-1.40)
H81 Excessive ear wax 4.7 1.3 1.34 (1.04-1.73) S18 Laceration/cut 4.3 2 0.75 (0.57-0.99)
S18 Laceration/cut 3.9 1.6 0.78 (0.61-0.99) U71 Cystitis/urinary infection, other 3.0 1.5 0.73 (0.53-1.01)
Abbreviations: MM multimorbidity, RR risk ratio, ICPC 2 International Classification of Primary Care, CI Cumulative incidence, NOS not otherwise specified.
*Cumulative incicidence was calculated as the sum of the number of new acute events during the study period divided by the 2010 population (e.g. if a patient passed two bronchitis in one year. the total number of
events accounted for was two).
#The outcome is the number of acute diseases in each person for each acute disease considered. RR of multimorbidity versus non-multimorbidity was calculated by Poisson, negative binomial (if overdispersion is
present) or zero inflated (when data showed excess of zero counts) equation as appropriate and adjusted for number of visits and area of residency. In bold P < 0.05.
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Table 4 Factors associated with multimorbidity by sex and age groups
Female
19-24 25-44 45-64 65-79 80+
OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value
Number of acute diseases(ref.0) 0.030 <0.001 <0.001 <0.001 <0.001
1 0.94 0.89-0.99 0.88 0.86-0.90 0.82 0.80-0.84 0.98 0.92-1.03 1.16 1.05-1.28
2 0.95 0.89-1.01 0.86 0.83-0.88 0.76 0.73-0.78 1.05 0.96-1.15 1.54 1.31-1.80
≥3 1.02 0.95-1.09 0.89 0.87-0.92 0.78 0.75-0.81 1.29 1.14-1.46 1.99 1.59-2.47
Rural area (ref. urban) 0.94 0.89-0.99 0.025 0.94 0.92-0.96 <0.001 0.80 0.78-0.82 <0.001 0.69 0.65-0.73 <0.001 0.76 0.70-0.83 <0.001
Number of visits (ref. 0) <0.001 <0.001 <0.001 <0.001 <0.001
1-2 2.09 1.93-2.26 2.34 2.28-2.14 3.40 3.30-3.51 3.62 3.38-3.87 3.41 3.08-3.78
3-5 3.52 3.25-3.80 4.04 3.93-4.15 7.54 7.31-7.77 10.18 9.54-10.86 8.36 7.55-9.27
6-10 5.69 5.25-6.17 7.11 6.91-7.32 16.28 15.76-16.81 25.98 24.28-27.80 18.86 16.99-20.94
≥11 9.93 9.09-10.85 14.52 14.05-14.99 43.03 41.39-44.73 90.81 83.74-98.48 45.19 40.69-50.19
Male
19-24 25-44 45-64 65-79 80+
OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value
Number of acute diseases(ref.0) <0.001 <0.001 <0.001 <0.001 0.590
1 0.78 0.73-0.83 0.71 0.70-0.73 0.67 0.65-0.69 0.84 0.80-0.89 1.07 0.95-1.21
2 0.79 0.73-0.86 0.64 0.62-0.66 0.58 0.56-0.60 0.78 0.72-0.85 1.08 0.89-1.31
≥3 0.76 0.69-0.83 0.60 0.58-0.62 0.55 0.52-0.57 0.86 0.77-0.97 1.12 0.88-1.42
Rural area (ref. urban) 0.94 0.88-1.00 0.045 0.95 0.93-0.97 <0.001 0.87 0.85-0.89 <0.001 0.71 0.68-0.75 <0.001 0.79 0.71-0.88 <0.001
Number of visits (ref. 0) <0.001 <0.001 <0.001 <0.001 <0.001
1-2 2.32 2.15-2.50 2.67 2.60-2.75 3.57 3.47-3.67 3.58 3.35-3.82 3.33 2.89-3.85
3-5 3.93 3.64-4.25 5.18 5.04-5.33 8.20 7.97-8.43 9.66 9.06-10.30 8.62 7.50-9.92
6-10 6.51 5.97-7.09 9.62 9.33-9.92 17.78 17.24-18.34 24.51 22.93-26.19 22.07 19.13-25.47
≥11 10.86 9.82-12.01 20.58 19.86-21.32 45.13 43.43-46.90 76.41 70.68-82.60 51.32 44.49-59.19
Logistic regression.
Abbreviations: OR odds ratio, CI confidence interval, ref. reference.
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http://www.biomedcentral.com/1471-2296/15/55of a disease [19]. Finally, a residual confounding cannot be
completely excluded, and could occur because of epi-
demiological factors not considered in this study, such as
patients’ socioeconomic status [20].
Strengths and weaknesses in relation to other studies
The estimated multimorbidity prevalence in our sample
is higher than in other European studies [21-24], perhaps
because of the analysis of a greater number of diseases
in our study than in most other published studies [25].
Nonetheless, the patterns of multimorbidity observed
were similar to those observed in other studies [26].
As in other studies, multimorbidity was more prevalent
among female [21,22,24]. This could be due to the longer
female life expectancy and worse health status, compared
to male, differences that are due to both biological and so-
cial factors [26]. In addition, sex is a social determinant
that influences health status, health behaviours and the use
of health services [27-30]. Recent studies, however, suggest
a dismantling of this paradigm based on sex-stratified ana-
lysis of consultations for common symptoms [31].
Acute problems are time-consuming for health profes-
sional [32], and therefore should be considered part of the
primary care workload. Although current health policy,
health care services, and research are all heavily focused
on chronic diseases, we must not forget that 41% of pri-
mary care visits are motivated by an acute disease [33].
The incidence of acute diseases observed in our study
concurs with other reports of acute upper respiratory
infection and other health problems of infectious aeti-
ology (acute tonsillitis, cystitis) as the primary reasons
for seeking primary care, along with non-infectious dis-
eases such as dorsalgia [33,34].
Our study observed a higher prevalence of multimorbid-
ity in rural settings. Other studies conducted in rural areas
have reported only a greater prevalence of multimorbidity
in elderly people [6,7]. Nonetheless, our adjusted analysis
showed that living in a rural area is negatively associated
with multimorbidity. This phenomenon could be due to
the environmental and sociocultural context and access to
both public and private services [28].
Implications for clinicians and policymakers
Our study considered multimorbidity in patients who
received primary medical care, considering all visits and
diagnoses (acute and chronic diseases). This approach
allowed the identification of vulnerable subgroups in
our population. A major advantage of our methodology
is the use of data obtained directly from standard clin-
ical practice. Knowing the distribution of acute and
chronic diseases by life-stage and sex will help the clin-
ician faced with a particular patient to anticipate disease
patterns based on the patient’s sex and stage of life, rec-
ognizing that these vary with age. This will encouragethe implementation of personalized disease prevention
and health promotion activities.
At the level of health policy and health care administra-
tion, the organization of services should be reviewed to
ensure that continuity and coordination of patient care are
guaranteed; current evidence suggests the potential for
improvement in this regard [35].
Unanswered questions and future research
The classification of chronic and acute disease remains
unresolved, and there is no consensus on the type and
number of chronic diseases that define multimorbidity.
A personalized measure to determine the severity of
diagnosed multimorbidity is also needed.
If longitudinal studies confirm a higher incidence of
morbidity in patients with multimorbidity, evidence-based
interventions will be needed to prevent the onset of acute
disease. Further studies are needed to study possible gen-
etic and pathophysiological explanations that corroborate
the observed multimorbidity patterns.
In-depth analysis of other contextual factors related to
multimorbidity is also required, along with studies of the
relationship between area of residence and multimorbidity
and of the differences in health status that may exist be-
tween different territories. Finally, there is a need for the
implementation and evaluation of health literacy and self-
management interventions to improve patient competence
in resolving routine acute diseases, which in turn will
decrease the care burden in primary care systems.
Conclusions
Multimorbidity is related to more use of health services
and higher incidence of acute diseases, which increases
the burden on primary care services. Residence in urban
vs rural settings is a factor for future in-depth study.
The association of acute morbidity, area of residency
or use of health services with multimorbidity differs
according to life-stage and sex. Therefore, the study of
multimorbidity should be stratified by life-stage and sex.
Understanding these trends across life-stages will allow
health systems to adjust their clinical and management
models to adapt and prioritize interventions.
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